These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 683012)

  • 1. Diabetogenic effects of somatostatin in maturity-onset diabetes and normal man: primacy of insulin deficiency rather than glucagon excess in the pathogenesis of diabetes.
    Sherwin RS; Tamborlane WV; Hendler R; Felig P
    Metabolism; 1978 Sep; 27(9 Suppl 1):1433-6. PubMed ID: 683012
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetogenic action of somatostatin in healthy subjects: effect of amino acids and somatostatin upon blood glucose, serum insulin, and glucagon.
    Waldhäusl WK; Bratusch-Marrain P; Loebenstein B
    Metabolism; 1978 Sep; 27(9 Suppl 1):1437-40. PubMed ID: 683013
    [No Abstract]   [Full Text] [Related]  

  • 3. Both glucagon excess and insulin deficiency characterize maturity-onset diabetes mellitus of youth (MODY).
    AvRuskin TW; Obilessetty V; Jabbar M; Prasad V; Greenfield E; Greig F; Juan CS
    J Pediatr Endocrinol; 1994; 7(4):335-41. PubMed ID: 7735372
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic effects of long-term somatostatin infusion in man.
    Gerich JE
    Metabolism; 1976 Nov; 25(11 Suppl 1):1505-7. PubMed ID: 988466
    [No Abstract]   [Full Text] [Related]  

  • 5. The diabetogenic action of somatostatin in healthy subjects and in maturity onset diabetics.
    Waldhäusl W; Bratusch-Marrain P; Dudczak R; Deutsch E
    J Clin Endocrinol Metab; 1977 May; 44(5):876-83. PubMed ID: 870515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin in maturity-onset diabetes.
    Christensen SE; Hansen AP; Lundbaek K
    Diabetes; 1978 Oct; 27(10):1013-9. PubMed ID: 700257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus.
    Wahren J
    Lancet; 1976 Dec; 2(7997):1213-6. PubMed ID: 63040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biphasic effect of somatostatin on oral glucose tolerance in maturity-onset diabetes.
    Tamborlane WV; Sherwin RS; Hendler R; Felig P
    Metabolism; 1978 Jul; 27(7):849-53. PubMed ID: 661568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin.
    Sherwin RS; Hendler R; DeFronzo R; Wahren J; Felic P
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):348-52. PubMed ID: 264686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon and diabetes.
    Raskin P; Unger RH
    Med Clin North Am; 1978 Jul; 62(4):713-22. PubMed ID: 355737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin, glucagon, and somatostatin in normal physiology and diabetes mellitus.
    Felig P; Wahren J; Sherwin R; Hendler R
    Diabetes; 1976 Dec; 25(12):1091-9. PubMed ID: 992227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibitory effect of somatostatin on growth hormone, insulin and glucagon secretion in diabetes mellitus.
    Ward FR; Leblanc H; Yen SS
    J Clin Endocrinol Metab; 1975 Sep; 41(3):527-32. PubMed ID: 1159060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged suppression of pituitary and pancreatic hormone release by a somatostatin analog.
    Lien EL; Fenichel RL; Grant NH; Boxill GC; Greenwood J; Yardley JP
    Biochem Biophys Res Commun; 1977 Aug; 77(4):1317-25. PubMed ID: 143285
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolic effects of somatostatin in maturity-onset diabetes.
    Tamborlane WV; Sherwin RS; Hendler R; Felig P
    N Engl J Med; 1977 Jul; 297(4):181-3. PubMed ID: 876274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of soy polysaccharide on postprandial plasma glucose, insulin, glucagon, pancreatic polypeptide, somatostatin, and triglyceride in obese diabetic patients.
    Tsai AC; Vinik AI; Lasichak A; Lo GS
    Am J Clin Nutr; 1987 Mar; 45(3):596-601. PubMed ID: 2881482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a 12-hour subcutaneous infusion of somatostatin-14 on blood glucose, insulin and glucagon levels in healthy subjects and insulin dependent diabetics.
    Villaume C; Beck B; Kolopp M; Toussain P; Debry G
    Biomed Pharmacother; 1986; 40(2):61-4. PubMed ID: 2875745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of glucagon in the pathogenesis of the endogenous hyperglycemia of diabetes mellitus.
    Sakurai H; Dobbs RE; Unger RH
    Metabolism; 1975 Nov; 24(11):1287-97. PubMed ID: 1186499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
    Rizza R; Verdonk C; Miles J; Service FJ; Gerich J
    J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twenty-four-hour somatostatin infusions in normals, juvenile diabetics, and maturity-onset diabetics.
    Christensen SE; Hansen AP; Orskov H; Lundbaek K
    Metabolism; 1978 Sep; 27(9 Suppl 1):1427-31. PubMed ID: 683011
    [No Abstract]   [Full Text] [Related]  

  • 20. The essential role of glucagon in the pathogenesis of diabetes mellitus.
    Unger RH; Orci L
    Lancet; 1975 Jan; 1(7897):14-6. PubMed ID: 46337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.